SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053615
Filing Date
2020-11-12
Accepted
2020-11-12 16:38:11
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q alxo-10q_20200930.htm 10-Q 2797873
2 EX-31.1 alxo-ex311_8.htm EX-31.1 18056
3 EX-31.2 alxo-ex312_7.htm EX-31.2 18182
4 EX-32.1 alxo-ex321_6.htm EX-32.1 9465
5 EX-32.2 alxo-ex322_9.htm EX-32.2 9438
  Complete submission text file 0001564590-20-053615.txt   7740745

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alxo-20200930.xml EX-101.INS 1323499
7 XBRL TAXONOMY EXTENSION SCHEMA alxo-20200930.xsd EX-101.SCH 53877
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alxo-20200930_cal.xml EX-101.CAL 49914
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alxo-20200930_def.xml EX-101.DEF 214296
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alxo-20200930_lab.xml EX-101.LAB 429083
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alxo-20200930_pre.xml EX-101.PRE 335730
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39386 | Film No.: 201307368
SIC: 2834 Pharmaceutical Preparations